Type 2 Diabetes Mellitus Model

Inquiry

Diabetes mellitus has become one of the broad endocrine diseases that threaten human health worldwide. Type 2 Diabetes Mellitus (T2DM) is the most common form of diabetes and is characterized by insulin resistance. It accounts for 90-95 % of all cases. And the development of T2DM is related to obesity, lack of physical exercise, aging and genetic predisposition. At present, the rodent is considered as a reliable model for discovering and validating new treatments for type 2 diabetes mellitus due to its small size, short generation time, etc.

Creative Bioarray specializes in providing customized pharmacodynamic research services to help customers assess the efficacy of drug candidates and study the associated pathological mechanisms through T2DM model.

Type 2 diabetes animal models include but not limited to:

Chemical-induced Type 2 Diabetes Models

Streptozotocin-induced Diabetes Mellitus Model

Transgenic Models

B6.Cg- Lepob/J Mouse Model
GK Rat Model

Diet-induced Type 2 Diabetes Models
Surgical Models

Species available

Rat
Mouse

Our capabilities

We detect blood glucose concentrations with a glucose meter.
We test the levels of LDL-c, HDL-c, creatinine, blood urea nitrogen (BUN) and so on by Elisa.

Assays available

Body weight measurement
Evaluation of blood glucose concentrations
Intraperitoneal glucose tolerance test
Biochemical analysis
Pathological evaluation

With extensive experience in the field of T2MD, we are confident to help you overcome any upcoming challenges. Our experts are fully capable of customizing our protocols and assays to meet your specific needs. With our help, we wish to facilitate your research with high efficiency.

Study examples

Figure. 1. T2DM-induced increase of the blood plasma levels of glucose (mmol/l, 48 h after STZ)

Quotation and ordering

If you have any special needs or questions regarding our services, please feel free to contact us at 631-626-9181 or info@creative-bioarray.com. We look forward to cooperating with you in the future.

Reference

Pechlivanova, Daniela, et al. "Protective effects of losartan on some type 2 diabetes mellitus-induced complications in Wistar and spontaneously hypertensive rats." Metabolic Brain Disease (2020): 1-12.